|   Chemical structure of guineesine | |
| Clinical data | |
|---|---|
| Other names | Guineensine; UNII-7DK8DMU9JX | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H33NO3 | 
| Molar mass | 383.532 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Guineesine (or guineensine) is a compound isolated from long pepper (Piper longum) [1] and black pepper (Piper nigrum). [2]
It was first isolated, studied and named from Piper guineense . [3] [4]
Guineensine inhibits the cellular reuptake of anandamide and 2-arachidonoylglycerol in a mouse model (EC50 = 290 nM). [5] [6] This causes an increase in the activity of the two neurotransmitters which are classified as endogenous cannabinoids.
Guineesine can dose-dependently produce cannabimimetic effects in a mouse model [5] which are indicated by potent catatonic, analgesic, hypo-locomotive and hypo-thermic effects. In addition, the analgesic and catatonic effects were reversed by the cannabinoid receptor type 1 (CB1) inverse agonist rimonabant. [5]
Guineesine is also a monoamine oxidase inhibitor (MAOI) in vitro (IC50 = 139.2 μM). [7]